Mechanical ventilation

Series
Pulmonary and airways
Status
Published
Date
Number of report
095

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for mechanical ventilation in European countries.

The following clinical indications will be considered:

  • Acute community-acquired viral pneumonia complicated with acute respiratory failure;
  • Severe sepsis due to acute community-acquired viral pneumonia with multiorgan failure (cardiac, respiratory and renal);
  • Acute hemorrhagic stroke with the development of coma.

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • England (UK)
  • Finland
  • France
  • Germany
  • Hungary
  • Italy
  • Netherlands
  • Norway
  • Romania
  • Russia
  • Sweden
  • Switzerland
  • Turkey

Manufacturers of devices for mechanical ventilation include:

  • Air Liquide (Monnal, CPX Care, eXtend, Orion)
  • Airon Mindray (E and SV Series)
  • Allied Healthcare (EPV200)
  • Breas Medical (Vivo)
  • Dräger (Savina, Evita, Oxylog)
  • Fisher & Paykel (F&P 850)
  • FLU (FEILON) (VG70 Invasive Ventilator)
  • GE Healthcare (CARESCAPE R860)
  • Getinge (Servo-u, Servo-air, Servo-I, Servo-s)
  • Hamilton Medical (HAMILTON-C1, HAMILTON-S1, HAMILTON-G5, HAMILTON-C3)
  • Medtronic (Puritan Bennett, Newport)
  • Philips Healthcare (Respironics BiPAP V30 Auto, Respironics V60, Respironics Trilogy 202, Respironics NM3, Respironics Respi-Link, Trilogy EV300)
  • ResMed (Astral, Stellar, Lumis)
  • Smiths Medical (PNEUPAC, PORTEX)
  • Schiller (GRAPHNET, GRAPHNET ADVANCE, AQUILON)
  • Teleflex (ConchaSmart, ISO-Gard, Comfort Flo)
  • Vyaire Medical (Avea CVS, BELLAVISTA)
  • WEINMANN (MEDUMAT)
  • Zoll Medical (Z Vent)

Table of content is not available at the moment. Report is still ongoing.

05

May 2020

In April 2020, the National Institute for Health and Care Excellence (NICE) published only one new medical technologies guidance (for PneuX to prevent ventilator-associated pneumonia) and two Medtech innovation briefings (for Lifelight First for monitoring vital signs and myCOPD for self-management of chronic obstructive pulmonary disease).

Read more

02

Apr 2020

The report presents a summary of the reimbursement situation for mechanical ventilation in Europe. The following clinical indications are considered: acute community-acquired viral pneumonia complicated with acute respiratory failure; severe sepsis due to acute community-acquired viral pneumonia with multiorgan failure (cardiac, respiratory and renal); acute hemorrhagic stroke with the development of com. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more
(we accept only company emails)